Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction

---
identifier: "/us/fr/2022-24666"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2022-24666"
section_name: "Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction"
positive_law: false
currency: "2022-11-14"
last_updated: "2022-11-14"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Science and Technology Policy Office"
document_number: "2022-24666"
document_type: "notice"
publication_date: "2022-11-14"
agencies:
  - "Science and Technology Policy Office"
fr_citation: "87 FR 68206"
fr_volume: 87
fr_action: "Notice of Request for Information (RFI); Correction."
---


#  Request for Information; Clinical Research Infrastructure and Emergency Clinical Trials; Correction

**AGENCY:**

Office of Science and Technology Policy (OSTP).

**ACTION:**

Notice of Request for Information (RFI); Correction.

**SUMMARY:**

The Office of Science and Technology Policy published a document in the *Federal Register* of October 25, 2022, concerning a request for information on Clinical Research Infrastructure and Emergency Clinical Trials. This document corrects an error in that notice.

**FOR FURTHER INFORMATION CONTACT:**

Scott Weaver, 202-456-4444.

**SUPPLEMENTARY INFORMATION:**

**Correction**

In the *Federal Register* of October 25, 2022, in FR Doc. 2022-23110, on page 64823, in the third column, in the first paragraph i., correct the first sentence to read:

i. As described above and in the forthcoming RFI on data capture, we are seeking information on how to create a pilot program enabling clinical trial data collection across a wide variety of trial sites that is easy for health care providers to use and can be scaled up for use in emergency research settings.

Dated: October 8, 2022.

Rachel Wallace,

Deputy General Counsel.